Indietro

Selezionare la regione

Azienda

Europa:

Bandiera Albanien Albanien Bandiera Bosnia ed Erzegovina Bosnia ed Erzegovina Bandiera Bulgaria Bulgaria Bandiera Croazia Croazia Bandiera Cyprus Cyprus Bandiera Montenegro Montenegro Bandiera Repubblica Ceca Repubblica Ceca Bandiera Danimarca Danimarca Bandiera Estonia Estonia Bandiera Spagna Spagna Bandiera Kosovo Kosovo Bandiera Lituania Lituania Bandiera Lettonia Lettonia Bandiera Lussemburgo Lussemburgo Bandiera Macedonia Macedonia Bandiera Germania Germania Bandiera Polonia Polonia Bandiera Portogallo Portogallo Bandiera Romania Romania Bandiera Serbia Serbia Bandiera Slovacchia Slovacchia Bandiera Slovenia Slovenia Bandiera Svizzera Svizzera Bandiera Svezia Svezia Bandiera Turchia Turchia Bandiera Ucraina Ucraina Bandiera Ungheria Ungheria Bandiera Regno Unito Regno Unito Bandiera Italia Italia

Asia:

Bandiera Emirati Arabi Uniti Emirati Arabi Uniti Bandiera Hong Kong Hong Kong Bandiera Kuwait Kuwait Bandiera Libano Libano

Africa:

Bandiera Sudafrica Sudafrica

Richiedi un consulto sulle cellule staminali

Per saperne di più

Mettetevi in contatto con noi oggi stesso!

Volete saperne di più sui nostri servizi? Compilate il modulo sottostante e vi contatteremo al più presto per fornirvi tutte le informazioni necessarie e rispondere alle vostre domande.

Errore: Modulo di contatto non trovato.

Immagine

I nostri trapianti

Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo Famicord.

Immagine
Lp.
Fonte
Tipo di fonte
Diagnosi
Settore medico
Anno di applicazione
Terapia
Paese
Età del destinatario
Tutti
Tutti
Tutti
Tutti
Tutti
Tutti
Tutti
Tutti
1
Cord Tissue
Allogeneic - Related
Chronic renal disease
Endocrinology
2025
Experimental Therapy
Romania
50
2
Cord Tissue
Allogeneic - Related
Autism
Neurology
2025
Experimental Therapy
Romania
6
3
Cord Tissue
Autologous
Autism
Neurology
2025
Experimental Therapy
Romania
6
4
Cord Tissue
Allogeneic - Unrelated
Degenerative and traumatic cartilage damage
Orthopedy
2025
Experimental Therapy
Poland
57
5
Cord Tissue
Allogeneic - Unrelated
Cerebral Palsy
Neurology
2025
Experimental Therapy
Poland
3
6
Cord Tissue
Allogeneic - Unrelated
Cerebral Palsy
Neurology
2025
Experimental Therapy
Poland
3
7
Cord Tissue
Allogeneic - Unrelated
Cerebral Palsy
Neurology
2025
Experimental Therapy
Poland
2
8
Cord Tissue
Allogeneic - Unrelated
Autism
Neurology
2025
Experimental Therapy
Poland
5
9
Cord Tissue
Allogeneic - Unrelated
Cerebral Palsy
Neurology
2025
Experimental Therapy
Poland
11
10
Cord Tissue
Allogeneic - Unrelated
Degenerative and traumatic cartilage damage
Orthopedics
2025
Experimental Therapy
Poland
54
11
Cord Tissue
Allogeneic - Unrelated
Degenerative and traumatic cartilage damage
Orthopedics
2025
Experimental Therapy
Poland
78
12
Cord Tissue
Allogeneic - Unrelated
Autism
Neurology
2025
Experimental Therapy
Poland
6
13
Cord Tissue
Allogeneic - Unrelated
Degenerative and traumatic cartilage damage
Orthopedics
2025
Experimental Therapy
Poland
58
14
Cord Tissue
Autologous
Autism
Neurology
2025
Experimental Therapy
Romania
5
15
Cord Tissue
Allogeneic - Related
Autism
Neurology
2025
Experimental Therapy
Romania
5
16
Cord Tissue
Allogeneic - Unrelated
Autism
Neurology
2025
Experimental Therapy
Poland
4
17
Cord Tissue
Allogeneic - Unrelated
Cerebral Palsy
Neurology
2025
Experimental Therapy
Poland
7
18
Cord Tissue
Allogeneic - Unrelated
Autism
Neurology
2025
Experimental Therapy
Poland
7
19
Cord Tissue
Allogeneic - Unrelated
Degenerative and traumatic cartilage damage
Orthopedy
2025
Experimental Therapy
Poland
25
20
Cord Tissue
Allogeneic - Unrelated
Autism
Neurology
2025
Experimental Therapy
Poland
6
21
Cord Tissue
Allogeneic - Unrelated
Progressive bulbar palsy
Neurology
2025
Experimental Therapy
Poland
62
22
Cord Tissue
Allogeneic - Unrelated
Encephalopathy
Neurology
2025
Experimental Therapy
Poland
67
23
Cord Blood
Allogeneic - Related
Thalassemia Major
Hematology
2025
Standard Therapy
Turkey
5
24
Cord Blood
Autologous
Aplastic Anemia
Hematology
2025
Standard Therapy
Poland
2
25
Cord Blood
Allogeneic - Related
Thalassemia Major
Hematology
2025
Standard Therapy
Turkey
6
26
Cord Blood
Allogeneic - Related
Cerebral Palsy
Neurology
2025
Experimental Therapy
Portugal
1
27
Cord Blood
Autologous
Autism
Neurology
2025
Experimental Therapy
Romania
5
28
Cord Blood
Allogeneic
Acute lymphoblastic leukemia
Hematology
2025
Standard Therapy
Poland
13
29
Cord Blood
Autologous
Autism
Neurology
2025
Experimental Therapy
Poland
5
30
Cord Blood
Autologous
Autism
Neurology
2025
Experimental Therapy
Poland
7
31
Cord Blood
Allogeneic
Thalassemia Major
Hematology
2025
Standard Therapy
Turkey
10
32
Cord Blood
Autologous
Autism
Neurology
2025
Experimental Therapy
Poland
4
33
Bone Marrow Family
Allogeneic
Myelofibrosis
Hematology
2025
Standard Therapy
Poland
71
34
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
United Kingdom
72
35
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
France
47
36
Bone Marrow Family
Allogeneic
Myelodysplastic Syndrome
Hematology
2025
Standard Therapy
Ukraine
43
37
Bone Marrow Family
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Italy
49
38
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
France
51
39
Bone Marrow Family
Allogeneic
Philadelphia - positive Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Germany
61
40
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
France
58
41
Bone Marrow Family
Allogeneic
Myelofibrosis
Hematology
2025
Standard Therapy
NETHERLANDS
63
42
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Poland
65
43
Bone Marrow Family
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
France
63
44
Bone Marrow Family
Allogeneic
Myelodysplastic Syndrome
Hematology
2025
Standard Therapy
Poland
68
45
Bone Marrow Family
Allogeneic
Myelofibrosis
Hematology
2025
Standard Therapy
France
71
46
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Russia
51
47
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Germany
62
48
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Czechia
54
49
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
United Kingdom
16
50
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
USA
61
51
Bone Marrow Family
Allogeneic
Chronic Myelomonocytic Leukemia
Hematology
2025
Standard Therapy
Poland
61
52
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Italy
70
53
Bone Marrow Family
Allogeneic
postET myelofibrosis
Hematology
2025
Standard Therapy
Netherlands
21
54
Bone Marrow Family
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Poland
68
55
Bone Marrow
Allogeneic
Aplastic Anemia
Hematology
2025
Standard Therapy
Spain
15
56
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
Norway
55
57
Bone Marrow
Allogeneic
Inherited Immune System Disorder
Hematology
2025
Standard Therapy
France
3
58
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
USA
7
59
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
Ukraine
36
60
Bone Marrow
Allogeneic
Inherited Immune System Disorder
Hematology
2025
Standard Therapy
France
10
61
Bone Marrow
Allogeneic
Myelodysplastic Syndrome
Hematology
2025
Standard Therapy
USA
76
62
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
Poland
39
63
Bone Marrow
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
South Africa
6
64
Bone Marrow
Allogeneic
Wiskott-Aldrich syndrome
Hematology
2025
Standard Therapy
Turkey
6
65
Bone Marrow
Allogeneic
Combined immnunodeficiency
Hematology
2025
Standard Therapy
Ukraine
3
66
Bone Marrow
Allogeneic
Chronic Granulomatous Disease
Hematology
2025
Standard Therapy
Poland
3
67
Bone Marrow
Allogeneic
Mixed Phenotype Acute Leukemia
Hematology
2025
Standard Therapy
Poland
13
68
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
Poland
7
69
Bone Marrow
Allogeneic
B-cell precursor Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Poland
56
70
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
Poland
43
71
Bone Marrow
Allogeneic
Myelodysplastic Syndrome
Hematology
2025
Standard Therapy
Poland
19
72
Bone Marrow
Allogeneic
Very Severe Aplastic Anemia
Hematology
2025
Standard Therapy
Poland
12
73
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Poland
5
74
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Poland
10
75
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
Poland
6
76
Bone Marrow
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Poland
44
77
Bone Marrow
Allogeneic
Paroxysmal Nocturnal Hemoglobinuria
Hematology
2025
Standard Therapy
Poland
25
78
Bone Marrow
Allogeneic
Juvenile Myelomonocytic Leukemia
Hematology
2025
Standard Therapy
Poland
4
79
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
USA
21
80
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Italy
12
81
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Hungary
10
82
Bone Marrow
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Czechia
68
83
Bone Marrow
Allogeneic
Adrenoleukodystrophy
Hematology
2025
Standard Therapy
Poland
53
84
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Germany
4
85
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
France
4
86
Bone Marrow
Allogeneic
Paroxysmal Nocturnal Hemoglobinuria
Hematology
2025
Standard Therapy
Norway
18
87
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
Spain
24
88
Bone Marrow
Allogeneic
Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Belarus
5
89
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
Germany
53
90
Bone Marrow
Allogeneic
diamond-Balckfan anemia
Hematology
2025
Standard Therapy
Germany
11
91
Bone Marrow
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Poland
57
92
Bone Marrow
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Poland
61
93
Bone Marrow
Allogeneic
Severe Aplastic Anemia
Hematology
2025
Standard Therapy
France
3
94
Bone Marrow
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Belarus
1
95
Bone Marrow
Allogeneic
pB-Acute Lymphoblastic Leukemia
Hematology
2025
Standard Therapy
Germany
15
96
Bone Marrow
Allogeneic
OHID XIAP - Other Histiocytic Disorders / X-Linked Inhibitor of Apoptosis Protein
Hematology
2025
Standard Therapy
Switzerland
2
97
Bone Marrow
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
USA
46
98
Bone Marrow
Allogeneic
Acquired Idiopathic Sideroblastic Anemia
Hematology
2025
Standard Therapy
Russian Federation
5
99
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
Germany
58
100
Apheresis
Allogeneic
Acute Myelogenous Leukemia
Hematology
2025
Standard Therapy
USA
34
Pagina
von78
100 Righe
Caricamento